Literature DB >> 24464714

GLP-1--a candidate humoral mediator for glucose control after Roux-en-Y gastric bypass.

Jörg Schirra1, Burkhard Göke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24464714     DOI： 10.2337/db13-1660

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  3 in total

1.  Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Authors:  Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; Alice P Liou; Margaret L Jackson; Dayan de Fontgalland; Philippa Rabbitt; Paul Hollington; Luigi Sposato; Steven Due; David A Wattchow; Jens F Rehfeld; Jens J Holst; Damien J Keating; Tina Vilsbøll; Filip K Knop
Journal:  JCI Insight       Date:  2018-12-06

2.  Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity.

Authors:  Jinying Chen; Zitai Sang; Lu Li; Linhong He; Liang Ma
Journal:  Mol Divers       Date:  2017-06-27       Impact factor: 2.943

Review 3.  Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery.

Authors:  Olivier F Noel; Christopher D Still; George Argyropoulos; Michael Edwards; Glenn S Gerhard
Journal:  J Obes       Date:  2016-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.